Marijuana Usage in Relation to Harmfulness Ratings, Perceived Likelihood of Negative Consequences, and Defense Mechanisms in High School Students

References

• Cushman P., Jr., Gupta S., Grieco M. H. Immunological studies in methadone maintained patients. Int. J. Addia. 1977; 12: 241–253
   PubMed Web of Science ®Google Scholar
• Donahoe R., Nicholson J. K. A., Madden J. J., et al. Coordinate and independent effects of heroin, cocaine, and alcohol abuse on T cell E-rosette formation and antigenic marker expression. Clin. Immunol. Immunopathol. 1986; 41: 254–264
   PubMedGoogle Scholar
• McDonough R. J., Madden J. J., Falek A., et al. Alteration of T and null lymphocyte frequencies in the peripheral flood of human opiate addicts: In vivo evidence for opiate receptors on T lymphocytes. J. Immunol. 1980; 125: 2539–2543
   PubMed Web of Science ®Google Scholar
• Shavit Y., Lewis J. W., Terman G. W. Opioid peptides mediate the suppressive effect of stress on natural killer cell cytoxicity. Science 1984; 223: 188–190
   PubMed Web of Science ®Google Scholar
• Peterson P. K., Gekker G., Brummit C, et al. Suppression of human peripheral blood mononuclear cell function by methadone and morphine. J. Infect. Dis. 1989; 159: 480–487
   Google Scholar
• Peterson P. K., Sharp B. M., Gekker G., et al. Morphine promotes the growth of HIV-1 in human periperal blood mononuclear cell cocultures. AIDS 1990; 4: 869–873
   PubMed Web of Science ®Google Scholar
• Tubaro E., Santiangeli C, Belogi L., et al. Methadone vs. morphine: Comparison of their effect on phagocytic functions. Int. J. Immunopharm. 1987; 9: 79–88
   PubMed Web of Science ®Google Scholar
• Hung C. Y., Lefkowitz S. S., Geber W. F. Interferon inhibition by narcotic analgesics. Proc. Soc. Exp. Biol. Med. 1973; 142: 106–111
   PubMed Web of Science ®Google Scholar
• Klimas N. G., Blaney N. T., Morgan R. O., et al. Immune function and anti-HTLV-I/II status in anti-HIV-1-negative intravenous drug users receiving methadone. Am. J. Med. 1991; 90: 163–170
   PubMedGoogle Scholar
• Mathews P. M., Froelich C. J., Sibbitt W. L. J., et al. Enhancement of natural cytoxicity by beta-endorphin. J. Immunol. 1983; 130: 1658–1662
   PubMed Web of Science ®Google Scholar
• Ochshorn M., Bodner G., Novick D. M., et al. The effect of methadone in vitro on natural killer (NK) activity. NIDA Res. Monogr. 1989; 95: 522–523
   PubMedGoogle Scholar
• Cherubin C. E., Millian S. J. Serologic investigations in narcotic addicts. Ann. Intern. Med. 1968; 69: 739–742
   PubMed Web of Science ®Google Scholar
• Kreek M. J. Immune function in heroin addicts and former heroin addicts in treatment: Pre-and post-AIDS epidemic. NIDA Res. Monogr. 1990; 96: 192–219
   PubMedGoogle Scholar
• Lazzarin A., Mella L., Trombini M., et al. Immunological status in heroin addicts: Effects of methadone maintenance treatment. Drug Alcohol Depend. 1984; 13: 117–123
   PubMed Web of Science ®Google Scholar
• Brown S. M., Stimmel B., Taub R. N., et al. Immunologic dysfunction in heroin addicts. Arch. Intern. Med. 1974; 134: 1001–1006
   PubMed Web of Science ®Google Scholar
• Cushman P., Jr., Grieco M. H. Hyperimmunoglobulinemia associated with narcotic addiction. Am. J. Med. 1973; 54: 320–326
   PubMed Web of Science ®Google Scholar
• Cushman P., Jr., Sherman C. Biologic false-positive reactions in serologic tests for syphilis in narcotic addiction. Am. J. Clin. Pathol. 1974; 61: 346–351
   PubMedGoogle Scholar
• Novick D. M., Ochshorn M., Ghali V., et al. Natural killer cell activity and lymphocyte subsets in parenteral heroin abusers and long-term methadone maintenance patients. J. Pharmacol. Exp. Ther. 1989; 250: 606–610
   PubMed Web of Science ®Google Scholar
• Des Jarlais D. C, Friedman S. R., Marmor M., et al. Development of AIDS, HTV seroconversion, and potential cofactors for T4 cell loss in a cohort of intravenous drug users. AIDS 1987; 1: 105–111
   PubMed Web of Science ®Google Scholar
• Mientjes G. H., Miedema F., van Ameijden E. J., et al. Frequent injecting impairs lymphocyte reactivity in HIV-positive and HIV-negative drug users. AIDS 1991; 5: 35–41
   PubMed Web of Science ®Google Scholar
• Gilman S. C, Schwartz J. M., Milner R. J., et al. Beta-endorphin enhances lymphocyte proliferative responses. Proc. Natl. Acad. Sci. USA 1982; 79: 4226–4230
   PubMed Web of Science ®Google Scholar
• Lopker A., Abood L. G., Hoss W., et al. Stereoselective muscarinic, acetylcholine and opiate receptors in human phagocytic leukocytes. Biochem. Pharmacol. 1980; 29: 1361–1365
   PubMed Web of Science ®Google Scholar
• Wybran J., Appelboom T., Famaey J.-P., et al. Suggestive evidence for receptors for morphine and methionine-enkephalin on normal human blood T lymphocytes. J. Immunol. 1979; 123: 1068–1070
   PubMed Web of Science ®Google Scholar
• Blalock J. E., Smith E. M. Human leukocyte interferon: Structural and biological relatedness to adrenocorticotropic hormone and endorphins. Proc. Natl. Acad. Sci. USA 1980; 77: 5972–5974
   PubMed Web of Science ®Google Scholar
• Smith E. M., Blalock J. E. Human lymphocyte production of corticotropin and endorphin-like substances: Association with leukocyte interferon. Proc. Natl. Acad. Sci. USA 1981; 78: 7530–7534
   PubMed Web of Science ®Google Scholar
• Weber R., Lederberger B., Opravil M., et al. Progression of HIV infection in misusers of injected drugs who stop injecting or follow a programme of maintenance treatment with methadone. Br. Med. J. 1990; 301: 1362–1365
   PubMed Web of Science ®Google Scholar
• Gorman J. M., Kertzner R., Todak G., et al. Multidisciplinary baseline assessment of homosexual men with and without human immunodeficiency virus infection. Arch. Gen. Psychiatry 1991; 48: 120–123
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control. Revision of the CDC surveillance definition for acquired immunodeficiency syndrome. Morbid. Mortal. Wkly. Rep. 1987; 36: 33–51S
   Google Scholar
• Hollingshead A. B. Two Factor Index of Social Position. Psychological Corporation, New York 1957
   Google Scholar
• Gorman J. M., Lange M., Dobkin J., et al. Development and characteristics of a medical staging system for HIV infection. Int. J. Methods Psychiatric Res. 1992; 2: 117–124
   Google Scholar
• Fauci A. S. The human immunodeficiency virus: Infectivity and mechanisms of pathogenesis. Science 1988; 239: 617–622
   PubMed Web of Science ®Google Scholar
• Galli M., Lazzarin A., Saracco A., et al. Clinical and immunological aspects of HIV infection in drug addicts. Clin. Immunol. Immunopathol. 1989; 50: S166–S176
   Google Scholar
• Novick D. M., Tregenza M. B., Solinas A., et al. T lymphocyte subsets in parenteral and non-parenteral heroin abusers in Britain. Br. J. Addict. 1986; 81: 679–683
   Google Scholar
• deShazo R. D., Naiyer C, Morgan J. E., et al. Immunologic assessment of a cluster of asymptomatic HTLV-I-infected individuals in New Orleans. Am. J. Med. 1989; 86: 65–70
   Google Scholar